Jean‐Baptiste Vulsteke

641 total citations
20 papers, 319 citations indexed

About

Jean‐Baptiste Vulsteke is a scholar working on Epidemiology, Pathology and Forensic Medicine and Dermatology. According to data from OpenAlex, Jean‐Baptiste Vulsteke has authored 20 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 8 papers in Pathology and Forensic Medicine and 7 papers in Dermatology. Recurrent topics in Jean‐Baptiste Vulsteke's work include Inflammatory Myopathies and Dermatomyositis (12 papers), Systemic Sclerosis and Related Diseases (8 papers) and Skin Diseases and Diabetes (5 papers). Jean‐Baptiste Vulsteke is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (12 papers), Systemic Sclerosis and Related Diseases (8 papers) and Skin Diseases and Diabetes (5 papers). Jean‐Baptiste Vulsteke collaborates with scholars based in Belgium, France and Netherlands. Jean‐Baptiste Vulsteke's co-authors include Ellen De Langhe, Xavier Bossuyt, Petra De Haes, Kishore S. Malyavantham, Minoru Satoh, Carolien Bonroy, Yves Piette, Michael Mähler, Yi‐Hsing Chen and Chih‐Wei Tseng and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Autoimmunity Reviews.

In The Last Decade

Jean‐Baptiste Vulsteke

19 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean‐Baptiste Vulsteke Belgium 10 229 112 81 77 57 20 319
Valérie Leclair Canada 11 306 1.3× 86 0.8× 58 0.7× 79 1.0× 80 1.4× 24 340
L. Bolko France 8 173 0.8× 141 1.3× 75 0.9× 58 0.8× 84 1.5× 20 320
Raffaele Bendo Italy 10 230 1.0× 150 1.3× 100 1.2× 65 0.8× 98 1.7× 13 381
Angeles S. Galindo‐Feria Sweden 10 191 0.8× 76 0.7× 73 0.9× 34 0.4× 68 1.2× 21 264
Melinda Nagy‐Vincze Hungary 9 357 1.6× 232 2.1× 59 0.7× 54 0.7× 97 1.7× 26 420
Hidemitsu Orito Japan 6 290 1.3× 207 1.8× 55 0.7× 90 1.2× 54 0.9× 8 372
Damien Amelin France 5 372 1.6× 149 1.3× 84 1.0× 44 0.6× 134 2.4× 9 433
Anke Rietveld Netherlands 7 206 0.9× 144 1.3× 97 1.2× 25 0.3× 64 1.1× 11 309
Elena Moraitis United Kingdom 8 204 0.9× 169 1.5× 76 0.9× 20 0.3× 52 0.9× 20 298
Jean‐Luc Senécal Canada 8 196 0.9× 125 1.1× 112 1.4× 89 1.2× 46 0.8× 8 312

Countries citing papers authored by Jean‐Baptiste Vulsteke

Since Specialization
Citations

This map shows the geographic impact of Jean‐Baptiste Vulsteke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Baptiste Vulsteke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Baptiste Vulsteke more than expected).

Fields of papers citing papers by Jean‐Baptiste Vulsteke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Baptiste Vulsteke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Baptiste Vulsteke. The network helps show where Jean‐Baptiste Vulsteke may publish in the future.

Co-authorship network of co-authors of Jean‐Baptiste Vulsteke

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Baptiste Vulsteke. A scholar is included among the top collaborators of Jean‐Baptiste Vulsteke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Baptiste Vulsteke. Jean‐Baptiste Vulsteke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bossuyt, Xavier, Jean‐Baptiste Vulsteke, Jan Van Elslande, et al.. (2023). Antinuclear antibodies in individuals with COVID-19 reflect underlying disease: Identification of new autoantibodies in systemic sclerosis (CDK9) and malignancy (RNF20, RCC1, TRIP13). Autoimmunity Reviews. 22(4). 103288–103288. 4 indexed citations
3.
Vulsteke, Jean‐Baptiste, Vanessa Smith, Carolien Bonroy, et al.. (2023). Autoantibodies against the NineTeen complex and U5 RNP in systemic sclerosis. Journal of Autoimmunity. 139. 103056–103056. 1 indexed citations
4.
Vulsteke, Jean‐Baptiste, Frédéric Coutant, David Gonçalves, et al.. (2023). Detection of anti-eIF2B autoantibodies in systemic sclerosis by immunoprecipitation-mass spectrometry. Lara D. Veeken. 62(7). e216–e218. 5 indexed citations
5.
Vulsteke, Jean‐Baptiste, Vanessa Smith, Carolien Bonroy, et al.. (2023). Identification of new telomere- and telomerase-associated autoantigens in systemic sclerosis. Journal of Autoimmunity. 135. 102988–102988. 11 indexed citations
6.
Vulsteke, Jean‐Baptiste, Yves Piette, Carolien Bonroy, et al.. (2022). Anti-RuvBL1/2 autoantibodies in patients with systemic sclerosis or idiopathic inflammatory myopathy and a nuclear speckled pattern. Annals of the Rheumatic Diseases. 81(5). 742–744. 10 indexed citations
7.
Vulsteke, Jean‐Baptiste, Rita Derua, Sylvain Dubucquoi, et al.. (2022). Mass spectrometry-based identification of new anti-Ly and known antisynthetase autoantibodies. Annals of the Rheumatic Diseases. 82(4). 546–555. 16 indexed citations
8.
Belmondo, Thibaut, et al.. (2022). Anti-Ki/anti-PA28γ autoantibodies contribute to the HEp-2 indirect immunofluorescence nuclear speckled pattern. Clinical Chemistry and Laboratory Medicine (CCLM). 61(3). 435–441. 1 indexed citations
9.
Vulsteke, Jean‐Baptiste, Xavier Bossuyt, Kristl G. Claeys, et al.. (2021). Detection of multiple myositis-specific autoantibodies in unique patients with idiopathic inflammatory myopathy: A single centre-experience and literature review. Seminars in Arthritis and Rheumatism. 51(2). 486–494. 10 indexed citations
10.
Vulsteke, Jean‐Baptiste, et al.. (2021). Can We Expect Any Effect of Rituximab on Fatigue in Primary Sjögren Syndrome?: A Systematic Review and Critical Appraisal.. PubMed. 27(8). e510–e515. 3 indexed citations
11.
Vulsteke, Jean‐Baptiste, et al.. (2020). Detection of anti-Mi-2 autoantibodies before dermatomyositis-specific manifestations. Lara D. Veeken. 59(10). e60–e62. 3 indexed citations
12.
Vulsteke, Jean‐Baptiste, Chris Verslype, & Ellen De Langhe. (2019). Candida albicans tenosynovitis of the hand. Lara D. Veeken. 58(10). 1889–1889. 2 indexed citations
13.
Vulsteke, Jean‐Baptiste, et al.. (2019). The role of high-resolution manometry in the assessment of upper gastrointestinal involvement in systemic sclerosis: a systematic review. Clinical Rheumatology. 39(1). 149–157. 13 indexed citations
14.
Vulsteke, Jean‐Baptiste, et al.. (2019). Can We Expect Any Effect of Rituximab on Fatigue in Primary Sjögren Syndrome?. JCR Journal of Clinical Rheumatology. 27(8). e510–e515. 3 indexed citations
15.
Vulsteke, Jean‐Baptiste, et al.. (2019). Physical therapy in adult inflammatory myopathy patients: a systematic review. Clinical Rheumatology. 38(8). 2039–2051. 22 indexed citations
16.
Vulsteke, Jean‐Baptiste, Minoru Satoh, Kishore S. Malyavantham, et al.. (2019). Anti-OJ autoantibodies: Rare or underdetected?. Autoimmunity Reviews. 18(7). 658–664. 47 indexed citations
17.
Damoiseaux, Jan, Jean‐Baptiste Vulsteke, Chih‐Wei Tseng, et al.. (2019). Autoantibodies in idiopathic inflammatory myopathies: Clinical associations and laboratory evaluation by mono- and multispecific immunoassays. Autoimmunity Reviews. 18(3). 293–305. 92 indexed citations
18.
Vulsteke, Jean‐Baptiste, et al.. (2019). Anti-TIF1-γ autoantibodies: warning lights of a tumour autoantigen. Lara D. Veeken. 59(3). 469–477. 41 indexed citations
19.
Vulsteke, Jean‐Baptiste & Dries Deeren. (2018). Cutaneous mucormycosis. Transplant Infectious Disease. 21(2). e13039–e13039. 5 indexed citations
20.
Vulsteke, Jean‐Baptiste, et al.. (2018). Rituximab in systemic autoimmune rheumatic diseases: indications and practical use. Acta Clinica Belgica. 74(4). 272–279. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valérie Leclair Breakdown of academic impact, for papers by L. Bolko Breakdown of academic impact, for papers by Raffaele Bendo Breakdown of academic impact, for papers by Angeles S. Galindo‐Feria Breakdown of academic impact, for papers by Melinda Nagy‐Vincze Breakdown of academic impact, for papers by Hidemitsu Orito Breakdown of academic impact, for papers by Damien Amelin Breakdown of academic impact, for papers by Anke Rietveld Breakdown of academic impact, for papers by Elena Moraitis Breakdown of academic impact, for papers by Jean‐Luc Senécal
Rankless by CCL
2026